834
Participants
Start Date
August 2, 2017
Primary Completion Date
May 3, 2018
Study Completion Date
June 14, 2019
MEDI0382 low dose
Pharmaceutical form: solution Route of administration: subcutaneous
MEDI0382 mid dose
Pharmaceutical form: solution Route of administration: subcutaneous
MEDI0382 high dose
Pharmaceutical form: solution Route of administration: subcutaneous
Placebo
Pharmaceutical form: solution Route of administration: subcutaneous
Liraglutide
Pharmaceutical form: solution Route of administration: subcutaneous
Research Site, Sofia
Research Site, Sofia
Research Site, Sofia
Research Site, Sofia
Research Site, Botevgrad
Research Site, Kyustendil
Research Site, Petrich
Research Site, Plovdiv
Research Site, Pleven
Research Site, Stara Zagora
Research Site, Rousse
Research Site, Berlin
Research Site, Berlin
Research Site, Brooklyn
Research Site, México
Research Site, Philadelphia
Research Site, Manassas
Research Site, Elkridge
Research Site, Hamburg
Research Site, Arlington
Research Site, Hamburg
Research Site, Lübeck
Research Site, Oldenburg
Research Site, Morehead City
Research Site, Greer
Research Site, Marietta
Research Site, Löhne
Research Site, Birmingham
Research Site, Magdeburg
Research Site, Guadalajara
Research Site, Essen
Research Site, Essen
Research Site, Evansville
Research Site, Münster
Research Site, Eschweiler
Research Site, Rhaunen
Research Site, Bridgeton
Research Site, Gelnhausen
Research Site, Aschaffenburg
Research Site, Monterrey
Research Site, Mannheim
Research Site, Metairie
Research Site, Baton Rouge
Research Site, Plano
Research Site, Houston
Research Site, Houston
Research Site, Villingen-Schwenningen
Research Site, Layton
Research Site, Mesa
Research Site, Chandler
Research Site, Glendale
Research Site, Glendale
Research Site, Las Vegas
Research Site, Veracruz
Research Site, Veracruz
Research Site, Hof
Research Site, Moscow
Research Site, Moscow
Research Site, Moscow
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Saint Petersburg
Research Site, Vladikavkaz
Research Site, Volgograd
Research Site, Izhevsk
Research Site, Chelyabinsk
Research Site, Perm
Research Site, Perm
Research Site, Yekaterinburg
Research Site, Novosibirsk
Research Site, Kemerovo
Research Site, Kozloduy
Research Site, Lukovit
Research Site, Red Deer
Research Site, Sherwood Park
Research Site, Burlington
Research Site, Etobicoke
Research Site, Guelph
Research Site, London
Research Site, London
Research Site, Newmarket
Research Site, Sarnia
Research Site, Thornhill
Research Site, Toronto
Research Site, Lévis
Research Site, Montreal
Research Site, Montreal
Research Site, Saint-Marc-des-Carrieres
Research Site, Beroun
Research Site, Jílové u Prahy
Research Site, Pardubice
Research Site, Pilsen
Research Site, Plzen - Severni Predmesti
Research Site, Prague
Research Site, Prague
Research Site, Prague
Research Site, Prague
Research Site, Praha Klanovice
Research Site, Uherské Hradiště
Research Site, Pirna
Research Site, México
Research Site, Banská Bystrica
Research Site, Bratislava
Research Site, Dolný Kubín
Research Site, Levice
Research Site, Lučenec
Research Site, Malacky
Research Site, Námestovo
Research Site, Nitra
Research Site, Nové Mesto nad Váhom
Research Site, Prievidza
Research Site, Rimavská Sobota
Research Site, Rožňava
Research Site, Sabinov
Research Site, Trebišov
Research Site, Trenčín
Research Site, Trnava
Research Site, Žilina
Lead Sponsor
Collaborators (1)
MedImmune LLC
INDUSTRY
AstraZeneca
INDUSTRY